Up
2005D-0103:
Guidance for Industry on Using a Centralized IRB Process in Multicenter
Clinical Trials
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| GDL1
|
| 03/25/2005
|
| 03/25/2005
|
| Federal Government
|
| Guidance
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Guidance
|
|
|
| NAD1
|
|
|
| 03/25/2005
|
| FDA
|
| FDA
|
| 03/28/2005
|
| 15635-15636
|
| 05/27/2005
|
| pdf
|
|
|
|
| Signature:
|
| SHUREN, JEFFREY
|
|
|
| C1
|
| 04/20/2005
|
| 04/18/2005
|
| Individual Consumer
|
| B. Lenich
|
|
|
|
|
|
|
|
|
|
|
|
|
| C2
|
| 04/28/2005
|
| 04/22/2005
|
| Health Professional
|
| J. Heubi, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
| C3
|
| 05/04/2005
|
| 05/03/2005
|
| Drug Industry
|
| Methapharm, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Anne Marie Hayes
|
|
|
| C4
|
| 05/16/2005
|
| 05/12/2005
|
| Private Industry
|
| Memorial Blood Centers
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Jed B. Gorlin
| |
|
| C5
|
| 05/25/2005
|
| 05/24/2005
|
| Private Industry
|
| AstraZeneca
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Gary M Cooper
|
|
|
| C6
|
| 05/27/2005
|
| 05/27/2005
|
| Association
|
| ASCO
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Sandra J. Horning, M.D.
|
|
|
| C7
|
| 05/27/2005
|
| 05/26/2005
|
| Private Industry
|
| Quorum Review, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Mark Mynhier
|
|
|
| C8
|
| 05/31/2005
|
| 05/27/2005
|
| Private Industry
|
| Novo Nordisk
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Mary Ann McElligott, PhD
|
|
|
| C9
|
| 05/31/2005
|
| 05/27/2005
|
| Association
|
| Council on Governmental
Relations (COGR)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Katharina Phillips
| |
|
| C10
|
| 06/02/2005
|
| 06/02/2005
|
| Private Industry
|
| Department of Public
Health HIV Vaccine Trials
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert Reinhard
| |
|
| EC1
|
| 06/17/2005
|
| 05/26/2005
|
| Drug Association
|
| Pharm Res
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Goldhammer, Alan
|
|
|
| EC2
|
| 06/17/2005
|
| 05/26/2005
|
| Health Professional
|
| Dr. Gary Chadwick
|
|
|
|
|
|
|
| htm
|
|
|
|
|
| EC3
|
| 06/17/2005
|
| 05/26/2005
|
| Academia
|
| Council on Governmental
Relations
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Phillips, Katharina
|
|
|
| EC4
|
| 06/17/2005
|
| 05/27/2005
|
| Health Care Association
|
| ASCO
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Horning, Sandra
|
|
|
| EC5
|
| 06/17/2005
|
| 05/27/2005
|
| Association
|
| Biotechnology Industry
Organization (BIO)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Aronson, Debra
|
|
|
| EC6
|
| 06/17/2005
|
| 05/27/2005
|
| Other Organization
|
| Consortium of Independent
Review Boards
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Freeman, John
|
|
|
| EC7
|
| 06/17/2005
|
| 05/28/2005
|
| Drug Industry
|
| Novartis
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Sadowski, Wayne
| |
|
| EMC1
|
| 05/26/2005
|
| 05/26/2005
|
| Individual Consumer
|
| R Reinhard, G Broder,
T Gibson, D Crawford
|
|
|
|
|
|
|
|
|
|
|
|
|
| C11
|
| 05/26/2005
|
| 05/24/2005
|
| Private Industry
|
| Quintiles Transnational
Corp
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Stephanie Branche
| |
|
| GDL2
|
| 03/15/2006
|
| 03/15/2006
|
| Federal Government
|
| Guidance
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Guidance
|
|
|
| NAD2
|
|
|
| 03/15/2006
|
| FDA
|
| FDA
|
| 03/16/2006
|
| 13605-13606
|
| 03/16/2007
|
| htm
|
|
|
|
| Signature:
|
| JEFFREY SHUREN
|
|
|
| EC8
|
| 07/05/2006
|
| 07/03/2006
|
| Individual Consumer
|
| Mr. David Lowe
|
|
|
|
|
|
|
| htm
|
|
|
|
|
| EC9
|
| 07/05/2006
|
| 07/04/2006
|
| Individual Consumer
|
| Mr. Dave Lowe
|
|
|
|
|
|
|
| htm
|
|
|
|
Top | Up
Page last updated
August 1, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |